Onset of Action of Biologics in Patients With Moderate-to-Severe Psoriasis.

CONCLUSIONS: Brodalumab may have the most rapid onset of action of any biologic therapy used in psoriasis. Similar results were seen with both outcome measures and will have important implications in psoriasis management. <p><em>J Drugs Dermatol. 2018;17(3):247-250.</em></p>. PMID: 29537442 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29537442?dopt=Abstract

Source: Journal of Drugs in Dermatology - March 17, 2018 Category: Dermatology Tags: J Drugs Dermatol Source Type: research